NEW YORK - The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP), a prominent cannabis cultivator, manufacturer, and retailer in the United States, announced leadership changes with David Hart taking over as Chief Executive Officer and Jesse Channon stepping in as President, effective immediately. The reshuffle comes as Nicholas Vita, co-founder of the company, retires from his CEO position but remains on the Board of Directors.
David Hart, previously the President and Chief Operating Officer, expressed his gratitude towards Vita for his foundational work and is eager to lead the company into its next phase, focusing on balance sheet strength, wholesale expansion, and organic growth. Hart joined The Cannabist Company in 2016 and has a background in healthcare investments and financial services.
Jesse Channon, who served as the Chief Commercial Officer before his appointment as President, highlighted the company's commitment to delivering high-quality experiences to customers and employees alike. Channon, an expert in digital marketing and transformative technologies, joined the company in December 2019.
Nicholas Vita, who co-founded The Cannabist Company in 2012 and has been at the helm for over a decade, oversaw the company's growth to over $500M in annual revenue and expansion into 16 integrated markets in the U.S. Vita is shifting his focus to research for ultrarare pediatric diseases through gene therapy but will continue to support the company as a Board member.
The Cannabist Company, which rebranded from Columbia Care (OTC:CBSTF), operates 125 facilities, including 94 dispensaries and 31 cultivation and manufacturing facilities. The company is known for its industry-leading products and services in both medical and adult-use cannabis markets and owns brands such as Seed & Strain, Triple Seven, and Classix.
This announcement is based on a press release statement and includes forward-looking statements regarding the company's future management and operational initiatives. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.